Viewing Study NCT02923934


Ignite Creation Date: 2025-12-25 @ 2:18 AM
Ignite Modification Date: 2025-12-31 @ 10:14 AM
Study NCT ID: NCT02923934
Status: COMPLETED
Last Update Posted: 2024-07-24
First Post: 2016-10-02
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase II Trial of Ipilimumab and Nivolumab for the Treatment of Rare Cancers
Sponsor: Olivia Newton-John Cancer Research Institute
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module